Geneos Wealth Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,425	Closed	-$30.4K	–	2460
2025 Q3	$30.4K	Buy	1,425 +756	+113%	+$17.9K	﹤0.01%	1560
2025 Q2	$14.4K	Buy	669 +50	+8%	+$929	﹤0.01%	2171
2025 Q1	$26.5K	Buy	619 +284	+85%	+$5.16K	﹤0.01%	2209
2024 Q4	$6.15K	Buy	335 +57	+21%	+$920	﹤0.01%	2254
2024 Q3	$4.28K	Buy	+278	New	+$4.64K	﹤0.01%	2117
2022 Q3	–	Sell	-450	Closed	-$6K	–	1996
2022 Q2	$6K	Hold	450	–	–	﹤0.01%	2111
2022 Q1	$10K	Hold	450	–	–	﹤0.01%	2078
2021 Q4	$10K	Hold	450	–	–	﹤0.01%	2161
2021 Q3	$7K	Hold	450	–	–	﹤0.01%	2326
2021 Q2	$10K	Hold	450	–	–	﹤0.01%	2186
2021 Q1	$9K	Hold	450	–	–	﹤0.01%	2402
2020 Q4	$11K	Hold	450	–	–	﹤0.01%	2166
2020 Q3	$18K	Hold	450	–	–	﹤0.01%	1689
2020 Q2	$21K	Hold	450	–	–	﹤0.01%	1587
2020 Q1	$17K	Hold	450	–	–	﹤0.01%	1566
2019 Q4	$19K	Hold	450	–	–	﹤0.01%	1701
2019 Q3	$16K	Sell	450 -417	-48%	-$12.6K	﹤0.01%	1698
2019 Q2	$23K	Hold	867	–	–	﹤0.01%	1557
2019 Q1	$23K	Hold	867	–	–	﹤0.01%	1496
2018 Q4	$13K	Hold	867	–	–	﹤0.01%	1680
2018 Q3	$17K	Sell	867 -2,300	-73%	-$36.2K	﹤0.01%	1641
2018 Q2	$48K	Hold	3,167	–	–	﹤0.01%	1062
2018 Q1	$71K	Buy	3,167 +3,017	+2,011%	+$83.5K	0.01%	864
2017 Q4	$4K	Buy	+150	New	+$4.8K	﹤0.01%	1853
2017 Q2	–	Sell	-63	Closed	-$2K	–	2066
2017 Q1	$2K	Hold	63	–	–	﹤0.01%	1851
2016 Q4	$1K	Hold	63	–	–	﹤0.01%	1917
2016 Q3	$2K	Buy	+63	New	+$2.14K	﹤0.01%	1739
2016 Q2	–	Sell	-1,000	Closed	-$28K	–	1800
2016 Q1	$28K	Buy	+1,000	New	+$21.8K	﹤0.01%	983